Montine KS - Search Results

1

Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Flanagan M, Larson EB, Latimer CS, Cholerton B, Crane PK, Montine KS, White LR, Keene CD, Montine TJ. Flanagan M, et al. Among authors: montine tj, montine ks. Biochim Biophys Acta. 2016 May;1862(5):945-51. doi: 10.1016/j.bbadis.2015.08.019. Epub 2015 Aug 28. Biochim Biophys Acta. 2016. PMID: 26319420 Free PMC article. Review.

2

Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.

Montine KS, Olson SJ, Amarnath V, Whetsell WO Jr, Graham DG, Montine TJ. Montine KS, et al. Among authors: montine tj. Am J Pathol. 1997 Feb;150(2):437-43. Am J Pathol. 1997. PMID: 9033259 Free PMC article.

3

4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.

Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 1997 Aug;56(8):866-71. doi: 10.1097/00005072-199708000-00004. J Neuropathol Exp Neurol. 1997. PMID: 9258256

4

Central nervous system lipoproteins in Alzheimer's disease.

Montine TJ, Montine KS, Swift LL. Montine TJ, et al. Among authors: montine ks. Am J Pathol. 1997 Dec;151(6):1571-5. Am J Pathol. 1997. PMID: 9403708 Free PMC article.

5

Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.

Montine KS, Reich E, Neely MD, Sidell KR, Olson SJ, Markesbery WR, Montine TJ. Montine KS, et al. Among authors: montine tj. J Neuropathol Exp Neurol. 1998 May;57(5):415-25. doi: 10.1097/00005072-199805000-00005. J Neuropathol Exp Neurol. 1998. PMID: 9596412

6

Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins.

Montine KS, Bassett CN, Ou JJ, Markesbery WR, Swift LL, Montine TJ. Montine KS, et al. Among authors: montine tj. J Lipid Res. 1998 Dec;39(12):2443-51. J Lipid Res. 1998. PMID: 9831633 Free article.

7

Cerebrospinal fluid lipoproteins in Alzheimer's disease.

Bassett CN, Montine KS, Neely MD, Swift LL, Montine TJ. Bassett CN, et al. Among authors: montine tj, montine ks. Microsc Res Tech. 2000 Aug 15;50(4):282-6. doi: 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T. Microsc Res Tech. 2000. PMID: 10936881 Review.

8

No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls.

Montine TJ, Shinobu L, Montine KS, Roberts LJ 2nd, Kowall NW, Beal MF, Morrow JD. Montine TJ, et al. Among authors: montine ks. Ann Neurol. 2000 Dec;48(6):950. Ann Neurol. 2000. PMID: 11117557 No abstract available.

9

Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls.

Montine TJ, Kaye JA, Montine KS, McFarland L, Morrow JD, Quinn JF. Montine TJ, et al. Among authors: montine ks. Arch Pathol Lab Med. 2001 Apr;125(4):510-2. doi: 10.5858/2001-125-0510-CFATAF. Arch Pathol Lab Med. 2001. PMID: 11260625 Free article.

10

Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment.

Montine KS, Montine TJ, Morrow JD, Frei B, Milatovic D, Eckenstein F, Quinn JF. Montine KS, et al. Among authors: montine tj. Brain Res. 2002 Mar 15;930(1-2):75-82. doi: 10.1016/s0006-8993(01)03409-6. Brain Res. 2002. PMID: 11879798

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page